Shibata et al. showed that chitin, when administered orally, inhibited allergen- induced IgE production and lung inflammation and resulted in a decrease in type 2 cytokines (in in vitro cultures) and these inhibitory effects were mediated by IFN-y produced by NK cells. The gene discussed is IGHE; the disease is inflammation.